Crescent Deferred Long Term Liab vs Total Liab Analysis

CCAP Stock

USD 19.36 0.14 0.73%

Crescent Capital financial indicator trend analysis is way more than just evaluating Crescent Capital BDC prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Crescent Capital BDC is a good investment. Please check the relationship between Crescent Capital Deferred Long Term Liab and its Total Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Crescent Capital BDC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Deferred Long Term Liab vs Total Liab

Deferred Long Term Liab vs Total Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Crescent Capital BDC Deferred Long Term Liab account and Total Liab. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Crescent Capital's Deferred Long Term Liab and Total Liab is -0.41. Overlapping area represents the amount of variation of Deferred Long Term Liab that can explain the historical movement of Total Liab in the same time period over historical financial statements of Crescent Capital BDC, assuming nothing else is changed. The correlation between historical values of Crescent Capital's Deferred Long Term Liab and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Deferred Long Term Liab of Crescent Capital BDC are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Deferred Long Term Liab i.e., Crescent Capital's Deferred Long Term Liab and Total Liab go up and down completely randomly.

Correlation Coefficient

-0.41

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Most indicators from Crescent Capital's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Crescent Capital BDC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Crescent Capital BDC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

At this time, Crescent Capital's Selling General Administrative is relatively stable compared to the past year. As of 12/02/2024, Enterprise Value Over EBITDA is likely to grow to 21.69, while Sales General And Administrative To Revenue is likely to drop 0.21.

	2021	2022	2023	2024 (projected)
Net Interest Income	69.5M	79.6M	115.0M	62.2M
Income Tax Expense	3.6M	961K	274K	260.3K

Net Interest Income Income Tax Expense

Crescent Capital fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Other Stockholder Equity	Total Liab	Long Term Investments	Total Current Assets	Common Stock
Total Assets		0.97	-0.43	0.73	1.0	0.99	0.92	-0.66	0.86	0.33	0.56	-0.08	0.78	0.94	0.55	0.84	0.95	0.53	0.94	0.37	0.95	1.0	1.0	1.0	-0.78	1.0
Short Long Term Debt Total	0.97		-0.44	0.7	0.97	0.96	0.89	-0.63	0.83	0.28	0.54	-0.34	0.8	0.9	0.52	0.78	0.93	0.36	0.9	0.36	0.91	0.96	0.96	0.97	-0.8	0.97
Other Current Liab	-0.43	-0.44		0.12	-0.47	-0.51	-0.21	-0.31	-0.35	0.11	-0.96	0.28	-0.41	-0.33	0.45	-0.27	-0.33	0.23	-0.33	-0.65	-0.35	-0.37	-0.39	-0.43	0.41	-0.47
Total Current Liabilities	0.73	0.7	0.12		0.7	0.67	0.89	-0.95	0.79	0.22	-0.02	0.09	0.64	0.83	0.86	0.76	0.82	0.53	0.83	-0.15	0.82	0.75	0.75	0.73	-0.64	0.71
Total Stockholder Equity	1.0	0.97	-0.47	0.7		1.0	0.92	-0.63	0.84	0.3	0.6	-0.13	0.79	0.95	0.51	0.83	0.95	0.49	0.95	0.43	0.95	0.99	0.99	1.0	-0.79	1.0
Net Tangible Assets	0.99	0.96	-0.51	0.67	1.0		0.9	-0.59	0.83	0.3	0.64	-0.14	0.79	0.94	0.47	0.82	0.94	0.47	0.94	0.46	0.94	0.98	0.98	0.99	-0.79	1.0
Net Debt	0.92	0.89	-0.21	0.89	0.92	0.9		-0.84	0.79	0.35	0.36	-0.02	0.76	0.98	0.76	0.88	0.99	0.59	0.98	0.18	0.98	0.92	0.92	0.92	-0.76	0.92
Retained Earnings	-0.66	-0.63	-0.31	-0.95	-0.63	-0.59	-0.84		-0.65	-0.23	0.19	-0.11	-0.51	-0.76	-0.92	-0.65	-0.76	-0.64	-0.76	0.27	-0.75	-0.7	-0.68	-0.66	0.51	-0.64
Accounts Payable	0.86	0.83	-0.35	0.79	0.84	0.83	0.79	-0.65		0.11	0.39	-0.02	0.73	0.79	0.48	0.73	0.79	0.36	0.79	0.12	0.79	0.87	0.88	0.86	-0.73	0.84
Cash	0.33	0.28	0.11	0.22	0.3	0.3	0.35	-0.23	0.11		0.12	0.17	0.14	0.28	0.53	0.51	0.31	0.53	0.28	0.16	0.27	0.3	0.35	0.32	-0.14	0.29
Non Current Assets Total	0.56	0.54	-0.96	-0.02	0.6	0.64	0.36	0.19	0.39	0.12		-0.19	0.51	0.48	-0.28	0.41	0.48	-0.01	0.48	0.73	0.49	0.5	0.53	0.56	-0.51	0.6
Non Currrent Assets Other	-0.08	-0.34	0.28	0.09	-0.13	-0.14	-0.02	-0.11	-0.02	0.17	-0.19		-0.27	-0.01	0.14	0.08	-0.11	0.63	-0.01	-0.25	-0.07	-0.09	-0.05	-0.09	0.27	-0.14
Other Assets	0.78	0.8	-0.41	0.64	0.79	0.79	0.76	-0.51	0.73	0.14	0.51	-0.27		0.79	0.39	0.63	0.81	0.18	0.79	0.38	0.8	0.77	0.76	0.78	-1.0	0.8
Long Term Debt	0.94	0.9	-0.33	0.83	0.95	0.94	0.98	-0.76	0.79	0.28	0.48	-0.01	0.79		0.64	0.86	0.99	0.55	1.0	0.32	1.0	0.94	0.93	0.94	-0.79	0.95
Cash And Short Term Investments	0.55	0.52	0.45	0.86	0.51	0.47	0.76	-0.92	0.48	0.53	-0.28	0.14	0.39	0.64		0.67	0.66	0.66	0.64	-0.23	0.63	0.57	0.57	0.55	-0.39	0.51
Net Receivables	0.84	0.78	-0.27	0.76	0.83	0.82	0.88	-0.65	0.73	0.51	0.41	0.08	0.63	0.86	0.67		0.86	0.51	0.86	0.35	0.85	0.81	0.84	0.84	-0.63	0.82
Common Stock Total Equity	0.95	0.93	-0.33	0.82	0.95	0.94	0.99	-0.76	0.79	0.31	0.48	-0.11	0.81	0.99	0.66	0.86		0.51	0.99	0.32	1.0	0.94	0.94	0.95	-0.81	0.95
Common Stock Shares Outstanding	0.53	0.36	0.23	0.53	0.49	0.47	0.59	-0.64	0.36	0.53	-0.01	0.63	0.18	0.55	0.66	0.51	0.51		0.55	-0.16	0.51	0.54	0.57	0.53	-0.18	0.49
Long Term Debt Total	0.94	0.9	-0.33	0.83	0.95	0.94	0.98	-0.76	0.79	0.28	0.48	-0.01	0.79	1.0	0.64	0.86	0.99	0.55		0.32	1.0	0.94	0.93	0.94	-0.79	0.95
Non Current Liabilities Total	0.37	0.36	-0.65	-0.15	0.43	0.46	0.18	0.27	0.12	0.16	0.73	-0.25	0.38	0.32	-0.23	0.35	0.32	-0.16	0.32		0.33	0.33	0.31	0.36	-0.38	0.41
Capital Surpluse	0.95	0.91	-0.35	0.82	0.95	0.94	0.98	-0.75	0.79	0.27	0.49	-0.07	0.8	1.0	0.63	0.85	1.0	0.51	1.0	0.33		0.94	0.93	0.95	-0.8	0.95
Other Stockholder Equity	1.0	0.96	-0.37	0.75	0.99	0.98	0.92	-0.7	0.87	0.3	0.5	-0.09	0.77	0.94	0.57	0.81	0.94	0.54	0.94	0.33	0.94		0.99	1.0	-0.77	0.99
Total Liab	1.0	0.96	-0.39	0.75	0.99	0.98	0.92	-0.68	0.88	0.35	0.53	-0.05	0.76	0.93	0.57	0.84	0.94	0.57	0.93	0.31	0.93	0.99		1.0	-0.76	0.99
Long Term Investments	1.0	0.97	-0.43	0.73	1.0	0.99	0.92	-0.66	0.86	0.32	0.56	-0.09	0.78	0.94	0.55	0.84	0.95	0.53	0.94	0.36	0.95	1.0	1.0		-0.78	1.0
Total Current Assets	-0.78	-0.8	0.41	-0.64	-0.79	-0.79	-0.76	0.51	-0.73	-0.14	-0.51	0.27	-1.0	-0.79	-0.39	-0.63	-0.81	-0.18	-0.79	-0.38	-0.8	-0.77	-0.76	-0.78		-0.8
Common Stock	1.0	0.97	-0.47	0.71	1.0	1.0	0.92	-0.64	0.84	0.29	0.6	-0.14	0.8	0.95	0.51	0.82	0.95	0.49	0.95	0.41	0.95	0.99	0.99	1.0	-0.8

Click cells to compare fundamentals

Crescent Capital Account Relationship Matchups

Crescent Capital fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	747.2M	1.1B	1.3B	1.3B	1.6B	886.5M
Short Long Term Debt Total	644.0M	471.9M	631.0M	654.5M	844.8M	462.1M
Other Current Liab	(12.1M)	(15.5M)	(18.2M)	(21.6M)	9.8M	10.3M
Total Current Liabilities	12.1M	15.5M	18.2M	21.6M	35.9M	37.7M
Total Stockholder Equity	406.9M	560M	652.3M	612.5M	742.6M	441.5M
Net Tangible Assets	406.9M	560M	652.3M	612.5M	704.4M	394.6M
Net Debt	317.4M	470.0M	621.0M	648.1M	837.0M	878.9M
Retained Earnings	(7.4M)	(34.7M)	(13.9M)	(62.5M)	(223.3M)	(212.2M)
Accounts Payable	12.1M	15.5M	18.2M	21.6M	26.1M	14.0M
Cash	4.6M	1.9M	10.1M	6.4M	7.8M	7.4M
Non Current Assets Total	727.3M	1.0B	1.3B	1.3B	114K	108.3K
Non Currrent Assets Other	(420.5B)	(630K)	(42M)	(91K)	(1.6B)	(1.7B)
Other Assets	12.3M	14.1M	13.6M	15.4M	1.6B	1.7B
Long Term Debt	150.8M	235.7M	322.0M	654.5M	752.6M	790.3M
Cash And Short Term Investments	4.6M	1.9M	10.1M	6.4M	24.5M	25.7M
Net Receivables	3.0M	3.9M	21.6M	10.0M	14.3M	15.0M
Common Stock Total Equity	13.4K	20.9K	28K	31K	35.7K	37.4K
Common Stock Shares Outstanding	17.3M	27.7M	28.5M	30.9M	35.9M	31.2M
Long Term Debt Total	150.8M	235.7M	322.0M	654.5M	752.6M	790.3M
Liabilities And Stockholders Equity	747.2M	1.1B	1.3B	1.3B	1.6B	886.5M
Non Current Liabilities Total	322.0M	471.9M	631.0M	21.6M	578K	549.1K
Capital Surpluse	170.8M	266.0M	414.3M	675.0M	776.3M	815.1M
Other Stockholder Equity	414.3M	594.7M	666.2M	675.0M	965.9M	483.9M
Total Liab	340.3M	494.2M	665.5M	690.3M	884.8M	445.0M
Long Term Investments	728.0M	1.0B	1.3B	1.3B	1.6B	863.2M
Total Current Assets	7.6M	5.8M	31.7M	16.3M	38.7M	36.8M
Common Stock	13.4K	20.9K	28K	31K	37K	22.0K
Other Liab	944K	2.2M	1.6M	1.1M	1.2M	1.2M
Net Invested Capital	728.9M	1.0B	1.3B	1.3B	1.6B	1.1B
Other Current Assets	(16.4M)	(18.7M)	(45.2M)	(27.0M)	(38.7M)	(36.8M)

Pair Trading with Crescent Capital

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Crescent Capital position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crescent Capital will appreciate offsetting losses from the drop in the long position's value.

Moving together with Crescent Stock

0.63	V	Visa Class A	Pair Corr
0.69	CG	Carlyle Group	Pair Corr
0.72	MA	Mastercard	Pair Corr
0.72	MS	Morgan Stanley Fiscal Year End 21st of January 2025	Pair Corr
0.77	APO	Apollo Global Management	Pair Corr

Moving against Crescent Stock

0.31

SWIN

Solowin Holdings Ordinary

Pair Corr

The ability to find closely correlated positions to Crescent Capital could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Crescent Capital when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Crescent Capital - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Crescent Capital BDC to buy it.

The correlation of Crescent Capital is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Crescent Capital moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Crescent Capital BDC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Crescent Capital can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Crescent Stock Analysis

When running Crescent Capital's price analysis, check to measure Crescent Capital's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crescent Capital is operating at the current time. Most of Crescent Capital's value examination focuses on studying past and present price action to predict the probability of Crescent Capital's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crescent Capital's price. Additionally, you may evaluate how the addition of Crescent Capital to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC